Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Monitoring of Tumor Specific Mutations in Patients With Lung Cancer

NCT03492801 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT03492801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03492801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Monitoring of Tumor Specific Mutations in Patients With Lung Cancer
Lead sponsor
University of Southern California
Phase
Observational
Overall status
Terminated
Start date
December 11, 2017
Completion date
November 21, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii non-small cell lung cancer ajcc v7, stage iiia non-small cell lung cancer ajcc v7, stage iiib non-small cell lung cancer ajcc v7, stage iv non-small cell lung cancer ajcc v7